200 related articles for article (PubMed ID: 12877935)
1. In vivo receptor occupancy of mGlu5 receptor antagonists using the novel radioligand [3H]3-methoxy-5-(pyridin-2-ylethynyl)pyridine).
Anderson JJ; Bradbury MJ; Giracello DR; Chapman DF; Holtz G; Roppe J; King C; Cosford ND; Varney MA
Eur J Pharmacol; 2003 Jul; 473(1):35-40. PubMed ID: 12877935
[TBL] [Abstract][Full Text] [Related]
2. [3H]Methoxymethyl-3-[(2-methyl-1,3-thiazol-4-yl)ethynyl]pyridine binding to metabotropic glutamate receptor subtype 5 in rodent brain: in vitro and in vivo characterization.
Anderson JJ; Rao SP; Rowe B; Giracello DR; Holtz G; Chapman DF; Tehrani L; Bradbury MJ; Cosford ND; Varney MA
J Pharmacol Exp Ther; 2002 Dec; 303(3):1044-51. PubMed ID: 12438526
[TBL] [Abstract][Full Text] [Related]
3. The behavioral profile of the potent and selective mGlu5 receptor antagonist 3-[(2-methyl-1,3-thiazol-4-yl)ethynyl]pyridine (MTEP) in rodent models of anxiety.
Busse CS; Brodkin J; Tattersall D; Anderson JJ; Warren N; Tehrani L; Bristow LJ; Varney MA; Cosford ND
Neuropsychopharmacology; 2004 Nov; 29(11):1971-9. PubMed ID: 15305166
[TBL] [Abstract][Full Text] [Related]
4. Transcriptional profiling of the rat frontal cortex following administration of the mGlu5 receptor antagonists MPEP and MTEP.
Gass JT; Olive MF
Eur J Pharmacol; 2008 Apr; 584(2-3):253-62. PubMed ID: 18346726
[TBL] [Abstract][Full Text] [Related]
5. In vitro characterization of [3H]MethoxyPyEP, an mGluR5 selective radioligand.
Patel S; Krause SM; Hamill T; Chaudhary A; Burns DH; Gibson RA
Life Sci; 2003 Jun; 73(3):371-9. PubMed ID: 12757844
[TBL] [Abstract][Full Text] [Related]
6. [3H]-methoxymethyl-MTEP and [3H]-methoxy-PEPy: potent and selective radioligands for the metabotropic glutamate subtype 5 (mGlu5) receptor.
Cosford ND; Roppe J; Tehrani L; Schweiger EJ; Seiders TJ; Chaudary A; Rao S; Varney MA
Bioorg Med Chem Lett; 2003 Feb; 13(3):351-4. PubMed ID: 12565928
[TBL] [Abstract][Full Text] [Related]
7. A close structural analog of 2-methyl-6-(phenylethynyl)-pyridine acts as a neutral allosteric site ligand on metabotropic glutamate receptor subtype 5 and blocks the effects of multiple allosteric modulators.
Rodriguez AL; Nong Y; Sekaran NK; Alagille D; Tamagnan GD; Conn PJ
Mol Pharmacol; 2005 Dec; 68(6):1793-802. PubMed ID: 16155210
[TBL] [Abstract][Full Text] [Related]
8. Anticonvulsant activity of two metabotropic glutamate group I antagonists selective for the mGlu5 receptor: 2-methyl-6-(phenylethynyl)-pyridine (MPEP), and (E)-6-methyl-2-styryl-pyridine (SIB 1893).
Chapman AG; Nanan K; Williams M; Meldrum BS
Neuropharmacology; 2000 Jul; 39(9):1567-74. PubMed ID: 10854901
[TBL] [Abstract][Full Text] [Related]
9. CTEP: a novel, potent, long-acting, and orally bioavailable metabotropic glutamate receptor 5 inhibitor.
Lindemann L; Jaeschke G; Michalon A; Vieira E; Honer M; Spooren W; Porter R; Hartung T; Kolczewski S; Büttelmann B; Flament C; Diener C; Fischer C; Gatti S; Prinssen EP; Parrott N; Hoffmann G; Wettstein JG
J Pharmacol Exp Ther; 2011 Nov; 339(2):474-86. PubMed ID: 21849627
[TBL] [Abstract][Full Text] [Related]
10. Blockade of the mGlu5 receptor decreases basal and stress-induced cortical norepinephrine in rodents.
Page ME; Szeliga P; Gasparini F; Cryan JF
Psychopharmacology (Berl); 2005 Apr; 179(1):240-6. PubMed ID: 15717212
[TBL] [Abstract][Full Text] [Related]
11. Metabotropic glutamate 5 receptor antagonism is associated with antidepressant-like effects in mice.
Li X; Need AB; Baez M; Witkin JM
J Pharmacol Exp Ther; 2006 Oct; 319(1):254-9. PubMed ID: 16803860
[TBL] [Abstract][Full Text] [Related]
12. The antinociceptive and anxiolytic-like effects of the metabotropic glutamate receptor 5 (mGluR5) antagonists, MPEP and MTEP, and the mGluR1 antagonist, LY456236, in rodents: a comparison of efficacy and side-effect profiles.
Varty GB; Grilli M; Forlani A; Fredduzzi S; Grzelak ME; Guthrie DH; Hodgson RA; Lu SX; Nicolussi E; Pond AJ; Parker EM; Hunter JC; Higgins GA; Reggiani A; Bertorelli R
Psychopharmacology (Berl); 2005 Apr; 179(1):207-17. PubMed ID: 15682298
[TBL] [Abstract][Full Text] [Related]
13. mGlu1 and mGlu5 receptor antagonists lack anticonvulsant efficacy in rodent models of difficult-to-treat partial epilepsy.
Löscher W; Dekundy A; Nagel J; Danysz W; Parsons CG; Potschka H
Neuropharmacology; 2006 Jun; 50(8):1006-15. PubMed ID: 16563443
[TBL] [Abstract][Full Text] [Related]
14. The mGlu5 receptor antagonists MPEP and MTEP attenuate behavioral signs of morphine withdrawal and morphine-withdrawal-induced activation of locus coeruleus neurons in rats.
Rasmussen K; Martin H; Berger JE; Seager MA
Neuropharmacology; 2005 Feb; 48(2):173-80. PubMed ID: 15695156
[TBL] [Abstract][Full Text] [Related]
15. Methoxyphenylethynyl, methoxypyridylethynyl and phenylethynyl derivatives of pyridine: synthesis, radiolabeling and evaluation of new PET ligands for metabotropic glutamate subtype 5 receptors.
Yu M; Tueckmantel W; Wang X; Zhu A; Kozikowski AP; Brownell AL
Nucl Med Biol; 2005 Aug; 32(6):631-40. PubMed ID: 16026710
[TBL] [Abstract][Full Text] [Related]
16. Metabotropic glutamate receptor mGlu5 is a mediator of appetite and energy balance in rats and mice.
Bradbury MJ; Campbell U; Giracello D; Chapman D; King C; Tehrani L; Cosford ND; Anderson J; Varney MA; Strack AM
J Pharmacol Exp Ther; 2005 Apr; 313(1):395-402. PubMed ID: 15590770
[TBL] [Abstract][Full Text] [Related]
17. Mutational analysis and molecular modeling of the binding pocket of the metabotropic glutamate 5 receptor negative modulator 2-methyl-6-(phenylethynyl)-pyridine.
Malherbe P; Kratochwil N; Zenner MT; Piussi J; Diener C; Kratzeisen C; Fischer C; Porter RH
Mol Pharmacol; 2003 Oct; 64(4):823-32. PubMed ID: 14500738
[TBL] [Abstract][Full Text] [Related]
18. Chronic treatment with MPEP, an mGlu5 receptor antagonist, normalizes basal ganglia glutamate neurotransmission in L-DOPA-treated parkinsonian monkeys.
Morin N; Morissette M; Grégoire L; Gomez-Mancilla B; Gasparini F; Di Paolo T
Neuropharmacology; 2013 Oct; 73():216-31. PubMed ID: 23756168
[TBL] [Abstract][Full Text] [Related]
19. Neuroprotective activity of the mGluR5 antagonists MPEP and MTEP against acute excitotoxicity differs and does not reflect actions at mGluR5 receptors.
Lea PM; Movsesyan VA; Faden AI
Br J Pharmacol; 2005 Jun; 145(4):527-34. PubMed ID: 15821750
[TBL] [Abstract][Full Text] [Related]
20. Anxiolytic-like effects of mGlu1 and mGlu5 receptor antagonists in rats.
Pietraszek M; Sukhanov I; Maciejak P; Szyndler J; Gravius A; Wisłowska A; Płaźnik A; Bespalov AY; Danysz W
Eur J Pharmacol; 2005 May; 514(1):25-34. PubMed ID: 15878321
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
